SCHEMBL7076818

SCHEMBL7076818

COC(=O)CC1Cc2ccc(C(=O)OC(C)(C)C)cc2NC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 4/20 0.43
HSD17B10 Q99714 4/20 0.43
GAA P10253 3/20 0.38
USP2 O75604 3/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 4/20 0.36
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
SRD5A1 P18405 1/20 0.35
MAPT P10636 3/20 0.35
KDM4E B2RXH2 2/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7078712 0.86 POLB (0.42) ALOX15HSD17B10GAAUSP2HTT
SCHEMBL7073177 0.85 DGAT1 (0.41) GAALMNAALDH1A1MAPTMEN1
SCHEMBL7078644 0.83 GAA (0.43) GAAHTTLMNAMAPTMEN1
SCHEMBL7073260 0.83 GAA (0.43) GAAMEN1KMT2AHPGD
SCHEMBL7073183 0.82 ITGB3 (0.33) ALOX15HSD17B10GAAUSP2HTT
SCHEMBL7073390 0.81 GAA (0.42) ALOX15HSD17B10GAAUSP2HTT
SCHEMBL7072903 0.80 USP2 (0.41) HSD17B10GAAUSP2HTTMEN1
SCHEMBL7076807 0.80 TERT (0.44) HSD17B10GAAHTTLMNAALDH1A1
SCHEMBL7076811 0.80 USP2 (0.36) ALOX15HSD17B10GAAUSP2HTT
SCHEMBL7072150 0.79 PDK2 (0.47) GAAALDH1A1MAPTKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030109523-A1 Bicyclic antagonists selective for the alphavbeta3 integrin WYETH (US) 2003-06-12 US disclosed
US-6429214-B1 INHIBITORS OF BONE RESORPTION WYETH 2002-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109523-A1 Bicyclic antagonists selective for the alphavbeta3 integrin ITGAV, ITGB2, ITGB3 ALOX15 3997/4885HSD17B10 3835/4885GAA 2157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.